Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, Jiangsu, China.
BMC Anesthesiol. 2021 Apr 6;21(1):106. doi: 10.1186/s12871-021-01321-w.
Bronchoscopy treatments of central airway obstruction (CAO) under general anesthesia are high-risky procedures, and posing a giant challenge to the anesthesiologists. We summarized and analyzed our clinical experience in patients with CAO undergoing flexible or rigid bronchoscopy, to estimate the safety of skeletal muscle relaxants application and the traditional Low-frequency ventilation.
Clinical data of 375 patients with CAO who underwent urgent endoscopic treatments in general anesthesia from January 2016 to October 2019 were retrospectively reviewed. The use ratio of skeletal muscle relaxants, dose of skeletal muscle relaxants used, the incidence of perioperative adverse events, adequacy of ventilation and gas exchange, post-operative recovery between rigid bronchoscopy and flexible bronchoscopy therapy, and risk factors for postoperative ICU admission were evaluated.
Of the 375 patients with CAO, 204 patients were treated with flexible bronchoscopy and 171 patients were treated with rigid bronchoscopy. Muscle relaxants were used in 362 of 375 patients (including 313 cisatracurium, 45 rocuronium, 4 atracurium, and 13 unrecorded). The usage rate of muscle relaxants (96.5% in total) was very high in patients with CAO who underwent either flexible bronchoscopy (96.6%) or rigid bronchoscopy (96.5%) therapy. The dosage of skeletal muscle relaxants (Cisatracium) used was higher in rigid bronchoscopy compared with flexible bronchoscopy therapy (10.8 ± 3.8 VS 11.6 ± 3.6 mg, respectively, p < 0.05). No patient suffered the failure of ventilation, bronchospasm and intraoperative cough either in flexible or rigid bronchoscopy therapy. Hypoxemia was occurred in 13 patients (8 in flexible, 5 in rigid bronchoscopy) during the procedure, and reintubation after extubation happened in 2 patients with flexible bronchoscopy. Sufficient ventilation was successfully established using the traditional Low-frequency ventilation with no significant carbon dioxide accumulation and hypoxemia occurred both in flexible and rigid bronchoscopy group (p > 0.05). Three patients (1 in flexible and 2 in rigid) died, during the post-operative recovery, and the higher grade of American Society of Anesthesiologists (ASA) and obvious dyspnea or orthopnea were the independent risk factors for postoperative ICU admission.
The muscle relaxants and low-frequency traditional ventilation can be safely used both in flexible and rigid bronchoscopy treatments in patients with CAO. These results may provide strong clinical evidence for optimizing the anesthesia management of bronchoscopy for these patients.
全身麻醉下的中央气道阻塞(CAO)支气管镜治疗是高风险的程序,对麻醉师来说是一个巨大的挑战。我们总结和分析了我们在 CAO 患者行柔性或刚性支气管镜检查时的临床经验,以评估骨骼肌松弛剂应用和传统低频通气的安全性。
回顾性分析 2016 年 1 月至 2019 年 10 月期间在全麻下接受紧急内镜治疗的 375 例 CAO 患者的临床资料。评估骨骼肌松弛剂的使用比例、使用的骨骼肌松弛剂剂量、围手术期不良事件发生率、通气和气体交换充足性、硬镜和软镜治疗后术后恢复情况,以及术后入住 ICU 的危险因素。
375 例 CAO 患者中,204 例行软镜治疗,171 例行硬镜治疗。375 例 CAO 患者中 362 例(包括 313 例顺式阿曲库铵、45 例罗库溴铵、4 例阿曲库铵、13 例未记录)使用了肌肉松弛剂。CAO 患者行软镜(96.6%)或硬镜(96.5%)治疗时,肌肉松弛剂的使用率(总使用率 96.5%)非常高。与软镜治疗相比,硬镜治疗时骨骼肌松弛剂(顺式阿曲库铵)的用量较高(分别为 10.8±3.8 和 11.6±3.6mg,p<0.05)。在软镜或硬镜治疗过程中,均未发生通气失败、支气管痉挛和术中咳嗽。术中 13 例(软镜 8 例,硬镜 5 例)患者发生低氧血症,2 例软镜治疗患者拔管后再次插管。软镜和硬镜组均采用传统低频通气成功建立充足通气,无明显二氧化碳蓄积和低氧血症(p>0.05)。3 例(软镜 1 例,硬镜 2 例)患者术后恢复期间死亡,美国麻醉医师协会(ASA)分级较高和明显呼吸困难或端坐呼吸是术后入住 ICU 的独立危险因素。
在 CAO 患者的软镜和硬镜治疗中,肌肉松弛剂和传统低频通气均可安全使用。这些结果可为优化此类患者支气管镜麻醉管理提供有力的临床证据。